TABLE 2.
Strain | Druga | SAB
|
10% FCS
|
||
---|---|---|---|---|---|
No. of atypical cells/total no. of cellsb | P valuec | No. of atypical cells/total no. of cellsb | P valuec | ||
ATCC 24067 | ⊘ | 12/80 | |||
FLU | 34/80 | <0.001 | |||
AmB | 47/80 | <0.001 | |||
ATCC 3501 | ⊘ | 10/80 | 7/40 | ||
FLU | 26/80 | 0.005 | 17/40 | 0.026 | |
AmB | 40/80 | <0.001 | 23/40 | <0.001 | |
CAP67 | ⊘ | 18/80 | 24/40 | ||
FLU | 53/80 | <0.001 | 38/40 | <0.001 | |
AmB | 57/80 | <0.001 | 40/40 | <0.001 |
Absence of drug (⊘) or either AmB or FLU at concentrations of 0.5 the MIC for the individual strain is indicated.
The ratio represents the number of atypical cells relative to the total number of cells counted by scanning electron microscopy. For ATCC 24067 and ATCC 3501, this describes the number of cells with aberrant or absent capsules versus the total number counted. For CAP67, this represents the number of round cells compared to the total number of cells evaluated.
P values were calculated by the chi-square test by using the results of an analysis of a drug-treated strain relative to the results of an analysis of the same strain without drug exposure.